Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Laquinimod in Relapsing-Remitting Multiple Sclerosis
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Multiple Sclerosis: An Update.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
BRIEF: Teva files for Copaxone-Laquinimod patent
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Trimesta (Oral Estriol)
Avonex drug warning letter, severe hypatic injury
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Neurological involvement in Primary Sjögren Syndrome.

Pages